BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension
NCT00863681
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
396
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension, Pulmonary
Interventions
DRUG:
Riociguat (BAY63-2521)
Sponsor
Bayer